JPS5215811A - Eye inserting substance and its preparation for eye drying diseases - Google Patents
Eye inserting substance and its preparation for eye drying diseasesInfo
- Publication number
- JPS5215811A JPS5215811A JP51089755A JP8975576A JPS5215811A JP S5215811 A JPS5215811 A JP S5215811A JP 51089755 A JP51089755 A JP 51089755A JP 8975576 A JP8975576 A JP 8975576A JP S5215811 A JPS5215811 A JP S5215811A
- Authority
- JP
- Japan
- Prior art keywords
- eye
- diseases
- preparation
- drying
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60016875A | 1975-07-29 | 1975-07-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5215811A true JPS5215811A (en) | 1977-02-05 |
JPS6122975B2 JPS6122975B2 (fr) | 1986-06-03 |
Family
ID=24402570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51089755A Granted JPS5215811A (en) | 1975-07-29 | 1976-07-29 | Eye inserting substance and its preparation for eye drying diseases |
Country Status (16)
Country | Link |
---|---|
US (1) | US4343787A (fr) |
JP (1) | JPS5215811A (fr) |
AU (1) | AU509140B2 (fr) |
BE (1) | BE844544A (fr) |
BR (1) | BR7604876A (fr) |
CH (1) | CH631891A5 (fr) |
CY (1) | CY1137A (fr) |
DE (1) | DE2633988C2 (fr) |
ES (3) | ES450002A1 (fr) |
FR (1) | FR2319375A1 (fr) |
GB (1) | GB1543189A (fr) |
HK (1) | HK282A (fr) |
IT (1) | IT1062653B (fr) |
NL (1) | NL188266C (fr) |
PT (1) | PT65389B (fr) |
SE (1) | SE431508B (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54145207A (en) * | 1978-04-30 | 1979-11-13 | Agency Of Ind Science & Technol | High viscosity eye lotion |
JPS58214128A (ja) * | 1982-04-29 | 1983-12-13 | チバ‐ガイギー アクチエンゲゼルシヤフト | アニ−ル処理ポリビニルアルコ−ルコンタクトレンズおよびその製法 |
WO2007013590A1 (fr) * | 2005-07-29 | 2007-02-01 | Santen Pharmaceutical Co., Ltd. | Système non invasif d'administration de médicament qui vise le tissu postérieur de l'œil au moyen d’une composition solide |
JP2011037891A (ja) * | 2002-09-30 | 2011-02-24 | Mark A Babizhayev | 薬剤組成物の製造のための水性眼科用組成物の使用、及び水性眼科用組成物 |
Families Citing this family (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4436730A (en) | 1979-06-25 | 1984-03-13 | Polymer Technology Corporation | Ionic opthalmic cellulose polymer solutions |
US4730013A (en) * | 1981-10-08 | 1988-03-08 | Merck & Co., Inc. | Biosoluble ocular insert |
EP0108661A1 (fr) * | 1982-10-04 | 1984-05-16 | Merck & Co. Inc. | Insertions oculaires en hydroxypropyl cellulose stabilisées et procédé de stérilisation |
US4565198A (en) * | 1983-12-27 | 1986-01-21 | Barnes-Hind, Inc. | Method for altering the curvature of the cornea |
US4660546A (en) * | 1984-11-07 | 1987-04-28 | Robert S. Herrick | Method for treating for deficiency of tears |
US5209927A (en) * | 1985-01-23 | 1993-05-11 | Alcon Laboratories, Inc. | Ophthalmic solution |
US4826871A (en) * | 1985-03-13 | 1989-05-02 | Gressel Philip D | Topical ophthalmic compositions containing one or more retinoids |
FR2588189B1 (fr) * | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
US4744980A (en) * | 1986-04-28 | 1988-05-17 | Holly Frank J | Ophthalmic solution for treatment of dry eye syndrome |
US4883658A (en) * | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
US5229128A (en) * | 1986-06-11 | 1993-07-20 | Haddad Heskel M | Drug delivery ophthalmic insert and method of preparing same |
US5322691A (en) * | 1986-10-02 | 1994-06-21 | Sohrab Darougar | Ocular insert with anchoring protrusions |
GB8623661D0 (en) * | 1986-10-02 | 1986-11-05 | Darougar S | Ocular insert |
US5989579A (en) * | 1986-10-02 | 1999-11-23 | Escalon Medical Corp. | Ocular insert with anchoring protrusions |
US4966773A (en) * | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
CA1317226C (fr) * | 1987-05-04 | 1993-05-04 | Phillip E. Pennell | Liquide visco-elastique pour chirurgie ophtalmique et methode d'utilisation |
US5075104A (en) * | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
GB8917216D0 (en) * | 1989-07-27 | 1989-09-13 | Smith & Nephew | Ophthalmic composition |
FR2688694B1 (fr) * | 1992-03-20 | 1999-06-25 | Vetoquinol Sa | Insert ophtalmique bioadhesif. |
MY113268A (en) * | 1992-12-29 | 2002-01-31 | Insite Vision Incorporated | Plasticized bioerodible controlled delivery system |
EP0732913B1 (fr) | 1993-04-30 | 2003-02-26 | Nestle S.A. | MATIERE VISCOELASTIQUE SYNTHETIQUE DESTINE A DES APPLICATIONS physiologiques tels que DES APPLICATIONS OPHTALMIQUEs |
US5631004A (en) | 1993-09-30 | 1997-05-20 | Alcon Laboratories, Inc. | Use of sustained release antibiotic compositions in ophthalmic surgical procedures |
TW274516B (fr) * | 1993-11-12 | 1996-04-21 | Ciba Geigy Ag | |
US5773021A (en) * | 1994-03-14 | 1998-06-30 | Vetoquinol S.A. | Bioadhesive ophthalmic insert |
US5466233A (en) * | 1994-04-25 | 1995-11-14 | Escalon Ophthalmics, Inc. | Tack for intraocular drug delivery and method for inserting and removing same |
US5472436A (en) * | 1994-07-26 | 1995-12-05 | Fremstad; Daria A. | Ocular appliance for delivering medication |
US5516808A (en) * | 1994-10-27 | 1996-05-14 | Sawaya; Assad S. | Topical cellulose pharmaceutical formulation |
US5518732A (en) * | 1995-02-14 | 1996-05-21 | Chiron Vision, Inc. | Bio-erodible ophthalmic shield |
DE19549506C2 (de) * | 1995-03-07 | 1998-07-30 | Richard Prof Dr Sueverkruep | Darreichungsform zur äußerlichen Applikation und Verfahren zur Herstellung derselben |
US6299895B1 (en) | 1997-03-24 | 2001-10-09 | Neurotech S.A. | Device and method for treating ophthalmic diseases |
US5888493A (en) * | 1996-12-05 | 1999-03-30 | Sawaya; Assad S. | Ophthalmic aqueous gel formulation and related methods |
US6193991B1 (en) * | 1997-10-29 | 2001-02-27 | Atul J. Shukla | Biodegradable delivery systems of biologically active substances |
WO2000051619A1 (fr) | 1999-03-01 | 2000-09-08 | Vista Scientific Llc | Preparations ophtalmiques contenant de la mucine |
US6264971B1 (en) * | 1999-11-04 | 2001-07-24 | Btg International Limited | Ocular insert |
US6613355B2 (en) | 2000-05-11 | 2003-09-02 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
US20050042194A1 (en) | 2000-05-11 | 2005-02-24 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
EP1299048A4 (fr) * | 2000-06-28 | 2005-09-28 | Atul J Shukla | Vehicules biodegradables et systemes d'administration de substances biologiquement actives |
US7404825B2 (en) * | 2001-06-11 | 2008-07-29 | Herrick Ii Robert S | Implant capable of forming a differential image in an eye |
WO2002100318A2 (fr) | 2001-06-12 | 2002-12-19 | Johns Hopkins University School Of Medicine | Dispositif a reservoir pour administration intra-oculaire de medicaments |
FR2833493B1 (fr) * | 2001-12-18 | 2005-09-23 | Ioltechnologie Production | Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble |
KR20060013632A (ko) * | 2002-05-17 | 2006-02-13 | 오쎄라 파마슈티걸즈, 인크. | 백내장 및 다른 안질환 발병의 개선 |
DE10246900A1 (de) | 2002-10-08 | 2004-04-22 | Horstmann, Michael, Dr. | Am Auge applizierbare Vorrichtung zur sicheren Dosierung systemischer und tropischer Medikation |
US7825134B2 (en) * | 2003-05-19 | 2010-11-02 | Othera Holding, Inc. | Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
US7947295B2 (en) * | 2003-06-13 | 2011-05-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
TWI336257B (en) * | 2003-06-13 | 2011-01-21 | Alcon Inc | Ophthalmic compositions containing a synergistic combination of three polymers |
CA2839898C (fr) * | 2003-06-13 | 2017-01-24 | Alcon, Inc. | Compositions ophtalmologiques contenant une association synergique de deux polymeres |
US7914803B2 (en) | 2003-06-13 | 2011-03-29 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of three polymers |
TWI347847B (en) * | 2003-08-20 | 2011-09-01 | Santen Pharmaceutical Co Ltd | Drug delivery system for sub-tenon administration of fine particles |
US8167855B2 (en) | 2003-08-26 | 2012-05-01 | Vista Scientific Llc | Ocular drug delivery device |
US7117870B2 (en) * | 2004-07-26 | 2006-10-10 | Clarity Corporation | Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same |
US20060020253A1 (en) * | 2004-07-26 | 2006-01-26 | Prescott Anthony D | Implantable device having reservoir with controlled release of medication and method of manufacturing the same |
US20060067978A1 (en) * | 2004-09-29 | 2006-03-30 | Bausch & Lomb Incorporated | Process for preparing poly(vinyl alcohol) drug delivery devices |
US20060068012A1 (en) * | 2004-09-29 | 2006-03-30 | Bausch & Lomb Incorporated | Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control |
US20070264338A1 (en) * | 2006-05-12 | 2007-11-15 | Shah Devang T | Base-stabilized polyorthoester formulations |
US20070264339A1 (en) * | 2006-05-12 | 2007-11-15 | Ap Pharma, Inc. | Base-stabilized polyorthoester formulations |
US20070265329A1 (en) * | 2006-05-12 | 2007-11-15 | Devang Shah T | Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) |
PL2109442T3 (pl) * | 2007-02-09 | 2014-07-31 | Novartis Ag | Kompozycje oftalmiczne zawierające synergistyczną kombinację trzech polimerów |
AU2008218783A1 (en) | 2007-02-22 | 2008-08-28 | Colby Pharmaceutical Company | Hydroxylamine compounds and methods of their use |
EP2370064A4 (fr) * | 2008-12-11 | 2012-09-19 | A P Pharma Inc | Procédés pour augmenter la stabilité de polyorthoesters et leurs formulations |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
US8399006B2 (en) | 2009-01-29 | 2013-03-19 | Forsight Vision4, Inc. | Posterior segment drug delivery |
WO2010101758A1 (fr) * | 2009-03-03 | 2010-09-10 | Alcon Research, Ltd. | Dispositif péricornéen d'administration de médicaments |
ES2921527T3 (es) | 2009-06-03 | 2022-08-29 | Forsight Vision5 Inc | Administración de fármaco en segmento anterior |
JP2013507373A (ja) * | 2009-10-08 | 2013-03-04 | ニューロテック ユーエスエー, インコーポレイテッド | 被包された細胞ベースの送達系におけるpedfの使用 |
US8469934B2 (en) * | 2010-01-27 | 2013-06-25 | Alcon Research, Ltd. | Pulsatile peri-corneal drug delivery device |
EP2585057B1 (fr) | 2010-06-25 | 2017-08-23 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Méthode de traitement en utilisant acide sterculique |
EP2598526B1 (fr) | 2010-07-29 | 2018-09-05 | Eleven Biotherapeutics, Inc. | Agonistes et antagonistes chimeriques du recepteur d'il-1 type i |
US9033911B2 (en) | 2010-08-05 | 2015-05-19 | Forsight Vision4, Inc. | Injector apparatus and method for drug delivery |
JP6111194B2 (ja) | 2010-08-05 | 2017-04-05 | フォーサイト・ビジョン フォー・インコーポレーテッド | 組み合わせ薬物送達方法および装置 |
US9492315B2 (en) | 2010-08-05 | 2016-11-15 | Forsight Vision4, Inc. | Implantable therapeutic device |
US20140031769A1 (en) | 2010-11-19 | 2014-01-30 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
US10398592B2 (en) | 2011-06-28 | 2019-09-03 | Forsight Vision4, Inc. | Diagnostic methods and apparatus |
EP2739252A4 (fr) | 2011-08-05 | 2015-08-12 | Forsight Vision4 Inc | Administration de petites molécules à l'aide d'un dispositif thérapeutique implantable |
US9102105B2 (en) | 2011-09-13 | 2015-08-11 | Vista Scientific Llc | Method for forming an ocular drug delivery device |
RU2740680C2 (ru) | 2011-09-14 | 2021-01-19 | Форсайт Вижн5, Инк. | Глазное вкладочное устройство и способы |
PT2755600T (pt) | 2011-09-16 | 2021-04-19 | Forsight Vision4 Inc | Aparelhos de troca de fluidos |
CN104884006B (zh) | 2012-10-26 | 2017-12-15 | 弗赛特影像5股份有限公司 | 用于持续释放药物到眼睛的眼科系统 |
DK2968468T3 (en) | 2013-03-13 | 2021-07-26 | Buzzard Pharmaceuticals AB | Chimeric cytokine formulations for ocular delivery |
EP2968113B8 (fr) | 2013-03-14 | 2020-10-28 | Forsight Vision4, Inc. | Systèmes pour l'administration intra-oculaire entretenue de composés à faible solubilité provenant d'un implant de système de pose d'orifice |
ES2972168T3 (es) | 2013-03-28 | 2024-06-11 | Forsight Vision4 Inc | Implante oftálmico para administración de sustancias terapéuticas |
MY182793A (en) | 2014-08-08 | 2021-02-05 | Forsight Vision4 Inc | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
CA2967330A1 (fr) | 2014-11-10 | 2016-05-19 | Forsight Vision4, Inc. | Dispositifs expansibles d'administration de medicament et methode d'utilisation |
WO2016168141A1 (fr) | 2015-04-13 | 2016-10-20 | Forsight Vision5, Inc. | Composition d'insert oculaire d'agent pharmaceutiquement actif cristallin ou semi-cristallin |
US10010502B2 (en) | 2015-05-19 | 2018-07-03 | Amorphex Therapeutics Llc | Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation |
MX2018006234A (es) | 2015-11-20 | 2018-08-14 | Forsight Vision4 Inc | Estructuras porosas para dispositivos de suministro de medicamentos de liberacion prolongada. |
EP3439591B1 (fr) | 2016-04-05 | 2020-09-23 | ForSight Vision4, Inc. | Dispositifs implantables d'administration de médicaments par voie oculaire |
BR112020010053A2 (pt) | 2017-11-21 | 2020-11-03 | Forsight Vision4, Inc. | aparelho para troca de fluido para sistema de liberação de porta expansível e métodos de uso do mesmo |
USD1033637S1 (en) | 2022-01-24 | 2024-07-02 | Forsight Vision4, Inc. | Fluid exchange device |
BE1030504B1 (fr) | 2022-05-06 | 2023-12-04 | Eyed Pharma | Insert composite pour le traitement de la sécheresse oculaire |
BE1030503B1 (fr) | 2022-05-06 | 2023-12-04 | Eyed Pharma | Insert pour le traitement de la sécheresse oculaire |
WO2023214027A1 (fr) | 2022-05-06 | 2023-11-09 | Eyed Pharma | Insert pour le traitement des yeux secs |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3856919A (en) * | 1970-06-08 | 1974-12-24 | Burton Parsons Chemicals Inc | Ophthalmic solution |
US3767788A (en) * | 1970-06-08 | 1973-10-23 | Burton Parsons Chemicals Inc | Ophthalmic solution |
SE352811B (fr) * | 1971-06-04 | 1973-01-15 | Pharmacia Ab | |
US3845201A (en) * | 1972-04-24 | 1974-10-29 | S Loucas | Solid state ophthalmic medication delivery method |
SE375007B (fr) * | 1972-11-30 | 1975-04-07 | Pharmacia Ab | |
US3875300A (en) * | 1972-12-18 | 1975-04-01 | Ortho Pharma Corp | Composition for sustained release of a medicament and method of using same |
US3911098A (en) * | 1974-02-11 | 1975-10-07 | American Cyanamid Co | Medicament carrier |
-
1976
- 1976-07-12 NL NLAANVRAGE7607704,A patent/NL188266C/xx not_active IP Right Cessation
- 1976-07-14 SE SE7608036A patent/SE431508B/xx not_active IP Right Cessation
- 1976-07-20 PT PT65389A patent/PT65389B/pt unknown
- 1976-07-21 ES ES450002A patent/ES450002A1/es not_active Expired
- 1976-07-21 AU AU16077/76A patent/AU509140B2/en not_active Expired
- 1976-07-22 IT IT50566/76A patent/IT1062653B/it active Protection Beyond IP Right Term
- 1976-07-26 CY CY1137A patent/CY1137A/xx unknown
- 1976-07-26 FR FR7622694A patent/FR2319375A1/fr active Granted
- 1976-07-26 GB GB31066/76A patent/GB1543189A/en not_active Expired
- 1976-07-27 BR BR7604876A patent/BR7604876A/pt unknown
- 1976-07-27 BE BE169261A patent/BE844544A/fr not_active IP Right Cessation
- 1976-07-28 CH CH964376A patent/CH631891A5/de not_active IP Right Cessation
- 1976-07-28 DE DE2633988A patent/DE2633988C2/de not_active Expired
- 1976-07-29 JP JP51089755A patent/JPS5215811A/ja active Granted
-
1977
- 1977-07-30 ES ES461216A patent/ES461216A1/es not_active Expired
- 1977-07-30 ES ES461217A patent/ES461217A1/es not_active Expired
-
1978
- 1978-12-28 US US05/973,975 patent/US4343787A/en not_active Expired - Lifetime
-
1982
- 1982-01-07 HK HK2/82A patent/HK282A/xx unknown
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54145207A (en) * | 1978-04-30 | 1979-11-13 | Agency Of Ind Science & Technol | High viscosity eye lotion |
JPS5648484B2 (fr) * | 1978-04-30 | 1981-11-16 | ||
JPS58214128A (ja) * | 1982-04-29 | 1983-12-13 | チバ‐ガイギー アクチエンゲゼルシヤフト | アニ−ル処理ポリビニルアルコ−ルコンタクトレンズおよびその製法 |
JPH0352842B2 (fr) * | 1982-04-29 | 1991-08-13 | Ciba Geigy | |
JP2011037891A (ja) * | 2002-09-30 | 2011-02-24 | Mark A Babizhayev | 薬剤組成物の製造のための水性眼科用組成物の使用、及び水性眼科用組成物 |
JP2011037892A (ja) * | 2002-09-30 | 2011-02-24 | Mark A Babizhayev | 治療手段 |
WO2007013590A1 (fr) * | 2005-07-29 | 2007-02-01 | Santen Pharmaceutical Co., Ltd. | Système non invasif d'administration de médicament qui vise le tissu postérieur de l'œil au moyen d’une composition solide |
Also Published As
Publication number | Publication date |
---|---|
ES461216A1 (es) | 1978-05-01 |
NL188266B (nl) | 1991-12-16 |
GB1543189A (en) | 1979-03-28 |
SE431508B (sv) | 1984-02-13 |
DE2633988C2 (de) | 1986-09-11 |
NL7607704A (nl) | 1977-02-01 |
NL188266C (nl) | 1992-05-18 |
CH631891A5 (en) | 1982-09-15 |
US4343787A (en) | 1982-08-10 |
DE2633988A1 (de) | 1977-02-10 |
ES450002A1 (es) | 1977-11-16 |
CY1137A (en) | 1982-05-07 |
BR7604876A (pt) | 1977-08-09 |
AU1607776A (en) | 1978-01-26 |
AU509140B2 (en) | 1980-04-24 |
BE844544A (fr) | 1977-01-27 |
SE7608036L (sv) | 1977-01-30 |
FR2319375B1 (fr) | 1982-07-23 |
PT65389A (en) | 1976-08-01 |
JPS6122975B2 (fr) | 1986-06-03 |
ES461217A1 (es) | 1978-05-01 |
FR2319375A1 (fr) | 1977-02-25 |
IT1062653B (it) | 1984-10-20 |
HK282A (en) | 1982-01-15 |
PT65389B (en) | 1978-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5215811A (en) | Eye inserting substance and its preparation for eye drying diseases | |
JPS5255291A (en) | Substance for inspection into eye | |
ZA766042B (en) | Pyridinyl-2(1h)-pyridinones and preparation | |
JPS52106877A (en) | Novel pyridinecarboxyamides and their preparation | |
JPS5289662A (en) | Novel polyhalogenoosteroid and preparation thereof | |
GB1538240A (en) | O-2-isocephem compounds and their preparation | |
JPS5297952A (en) | Aminoalcohol derivatives and preparation thereof | |
IL50503A (en) | Substituted 2-aminopyrimidin-4-ones and pyrimidine-4-thiones and process for their preparation | |
JPS5262399A (en) | Polyamideterpolymer and preparation thereof | |
IL49516A (en) | 3-amino-4-deoxo-4-imino and amino-rifamycins and their preparation | |
IL50657A (en) | 11-deoxy-16-aryl- -tetranor-prosta-cis-5-ene-13-yneoic acid derivatives and their preparation | |
JPS51138609A (en) | 12222tetrafluoroethyll fluoromethilether and its preparation | |
GB1553661A (en) | P-amino-methyl-benzene-sulphonamide derivatives process for their preparation and application thereof | |
IL50080A0 (en) | New azabicycloheptanes and their preparation | |
JPS51126281A (en) | Cytootoxic substance | |
JPS5212175A (en) | Triazaspirodecanone derivatives and preparation method thereof | |
JPS524585A (en) | Polyvinylacetate dispersion and preparation thereof | |
GR59335B (en) | Anthraquinono-bis-amidines and preparation process thereo | |
JPS51148099A (en) | Smoking substance | |
JPS5217478A (en) | New homophthalimide derivatives and preparation method thereof | |
JPS5212158A (en) | Epoxyandrostane and preparation thereof | |
JPS5251364A (en) | Thiazolizine derivatives and preparation thereof | |
JPS523060A (en) | Paraachlorophenoxyisobutyric acid derivatives and preparation thereof | |
JPS51122008A (en) | Dimercaptoethylether derivative preparation method and medicine containing same | |
IL49208A0 (en) | Fluoro-prostaglandins and process for their preparation |